What is Diabetes?

Diabetes occurs when the body is no longer able to make insulin, or when the body cannot make good use of the insulin produces. Insulin is essential for the body to use glucose from food to produce energy. Not being able to produce insulin or use it effectively leads to raised glucose levels in the blood, known as hyperglycaemia. Over the long-term, high glucose levels are associated with damage to the body and failure of various organs and tissues.

Type 1 diabetes is caused by an auto-immune disorder where the body’s defence system attacks the insulin-producing cells located in the pancreas, resulting in an inability to produce insulin. Type 2 diabetes develops a result of factors related to environment, lifestyle and genetic predisposition. People with Type 2 diabetes produce insulin, however, it is not enough for the body to function with.

Asia Pacific

The largest diabetes epidemic


Asia Pacific has

36.6%

of the world’s total population living with diabetes

Diabetes and complications from diabetes contribute to

1.35 million

deaths in Asia Pacific per year

There are 94.5 million undiagnosed cases of diabetes in Asia Pacific.

Addressing the Challenges of Invasive Glucose Monitoring

Glucose monitoring is critical for people living with diabetes to sustain good health. Currently, the only approved methods for testing glucose levels are painful and invasive. Because of this, many people with diabetes do not test as often as clinically recommended, increasing the risk of complications.

Download our industry paper to learn more on:

  • The challenges of current glucose monitoring technologies
  • The urgent need for non-invasive glucose monitoring
  • How non-invasive glucose monitoring will help millions of people with diabetes

Replacing Finger-pricks

Our technology replaces the need for finger-prick blood glucose testing

1
Place the Saliva Glucose Biosensor in contact with saliva.
2
With biosensor nearby, the digital app displays the glucose measurement, flagging any that need attention.
3
The app provides real-time comparisons with historical data, and sends data to electronic medical record or caregiver.

For illustrative purposes only and has yet to receive regulatory approval in any jurisdiction.

Sign Up

Register for email alerts for the latest on the Biosensor Platform and GBS Inc.

  • This field is for validation purposes and should be left unchanged.